‘Breakthrough’ blood test could spot ‘fingerprints’ of chronic condition affecting millions 190 million women worldwide grapple with endometriosis, often facing an agonising wait time for a diagnosis, currently averaging nearly eight years in the UK.
The Perth-based company has created a ground breaking PromarkerEndo blood test that holds the potential to dramatically reduce the agonisingly long average wait time for a diagnosis, which even sits at seven years in Australia, as well as cutting costs for both patients and healthcare providers.
Scientists have made a "significant step" towards developing a quick, non-invasive blood test after discovering a unique blood "fingerprint" indicative of the chronic disease.
This cutting-edge test can reportedly detect all stages of endometriosis with impressive accuracy, even able to distinguish people in the earliest stages of the condition from those merely exhibiting symptoms.
Currently, the diagnosis procedure involves invasive methods such as transvaginal ultrasounds or laparoscopy, a surgical process where a camera is inserted into the pelvis and suspicious tissue potentially removed for lab analysis.
